INmune Bio Inc (INMB)
10.98
-0.20
(-1.75%)
USD |
NASDAQ |
May 17, 16:00
10.98
0.00 (0.00%)
After-Hours: 20:00
INmune Bio Price to Book Value: 7.396 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 7.396 |
| May 16, 2024 | 7.614 |
| May 15, 2024 | 7.743 |
| May 14, 2024 | 7.150 |
| May 13, 2024 | 6.762 |
| May 10, 2024 | 6.830 |
| May 09, 2024 | 7.341 |
| May 08, 2024 | 7.136 |
| May 07, 2024 | 7.612 |
| May 06, 2024 | 7.626 |
| May 03, 2024 | 7.878 |
| May 02, 2024 | 7.578 |
| May 01, 2024 | 7.898 |
| April 30, 2024 | 8.062 |
| April 29, 2024 | 8.014 |
| April 26, 2024 | 7.304 |
| April 25, 2024 | 7.012 |
| April 24, 2024 | 6.870 |
| April 23, 2024 | 6.360 |
| April 22, 2024 | 6.664 |
| April 19, 2024 | 5.250 |
| April 18, 2024 | 5.519 |
| April 17, 2024 | 5.287 |
| April 16, 2024 | 5.739 |
| April 15, 2024 | 6.009 |
| Date | Value |
|---|---|
| April 12, 2024 | 6.517 |
| April 11, 2024 | 6.862 |
| April 10, 2024 | 6.705 |
| April 09, 2024 | 6.531 |
| April 08, 2024 | 6.408 |
| April 05, 2024 | 6.395 |
| April 04, 2024 | 6.340 |
| April 03, 2024 | 6.247 |
| April 02, 2024 | 6.773 |
| April 01, 2024 | 7.125 |
| March 31, 2024 | |
| March 28, 2024 | 5.554 |
| March 27, 2024 | 5.497 |
| March 26, 2024 | 5.592 |
| March 25, 2024 | 5.512 |
| March 22, 2024 | 5.742 |
| March 21, 2024 | 5.610 |
| March 20, 2024 | 5.455 |
| March 19, 2024 | 5.149 |
| March 18, 2024 | 5.187 |
| March 15, 2024 | 5.206 |
| March 14, 2024 | 5.384 |
| March 13, 2024 | 5.559 |
| March 12, 2024 | 5.535 |
| March 11, 2024 | 5.516 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.006
Minimum
Mar 18 2020
11.49
Maximum
Sep 07 2021
3.497
Average
2.718
Median
Oct 20 2020
Price to Book Value Benchmarks
| Biomarin Pharmaceutical Inc | 2.903 |
| Sarepta Therapeutics Inc | 12.92 |
| Dare Bioscience Inc | -- |
| Zevra Therapeutics Inc | 4.055 |
| Kodiak Sciences Inc | 0.7188 |
Price to Book Value Related Metrics
| PS Ratio | 1490.90 |
| PEG Ratio | -0.1958 |
| Price | 10.98 |
| Earnings Yield | -17.70% |
| Market Cap | 214.64M |
| PEGY Ratio | -0.1958 |